Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · IEX Real-Time Price · USD
7.69
+0.30 (4.06%)
Mar 28, 2024, 2:55 PM EDT - Market open

Inozyme Pharma Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Inozyme Pharma stock have an average target of 18, with a low estimate of 15 and a high estimate of 23. The average target predicts an increase of 134.07% from the current stock price of 7.69.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $15 $18 $16 $23
Change +95.06% +134.07% +108.06% +199.09%

Analyst Ratings

The average analyst rating for Inozyme Pharma stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '23Nov '23Dec '23Jan '24Feb '24Mar '24
Strong Buy 333332
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 444443

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$16
Strong Buy Maintains $16 +108.06% Mar 13, 2024
Needham
Needham
Strong Buy
Reiterates
$23
Strong Buy Reiterates $23 +199.09% Mar 12, 2024
Wedbush
Wedbush
Buy
Reiterates
$15
Buy Reiterates $15 +95.06% Jan 30, 2024
Needham
Needham
Strong Buy
Reiterates
$23
Strong Buy Reiterates $23 +199.09% Nov 8, 2023
Needham
Needham
Strong Buy
Reiterates
$23
Strong Buy Reiterates $23 +199.09% Sep 27, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.37
from -1.37
EPS Next Year
-1.51
from -1.37
Year 2019202020212022202320242025202620272028
Revenue
-------13.37M118.87M315.06M
Revenue Growth
--------788.95%165.05%
EPS
-16.67-5.11-2.40-1.78-1.37-1.37-1.51-1.30-0.140.69
EPS Growth
----------
No. Analysts -----98443
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High n/a n/a 39.1M 238.2M 560.0M
Avg n/a n/a 13.4M 118.9M 315.1M
Low n/a n/a 2.7M 31.9M 160.6M

Revenue Growth

Revenue Growth 20242025202620272028
High - - -
1,681.4%
371.1%
Avg - - -
788.9%
165.0%
Low - - -
138.2%
35.1%

EPS Forecast

EPS 20242025202620272028
High -1.16 -1.31 -1.24 0.43 0.71
Avg -1.37 -1.51 -1.30 -0.14 0.69
Low -1.62 -1.81 -1.33 -0.67 0.67

EPS Growth

EPS Growth 20242025202620272028
High - - - - -
Avg - - - - -
Low - - - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.